Dr Soyini Hawkins: Treating Endometriosis Requires Goals for the Rest of a Patient’s Life
Since endometriosis is a chronic disease, treating it cannot be approached with a “one-and-done” mentality, said Soyini Hawkins, MD, gynecologist at Fibroid and Pelvic Wellness Center of Georgia.
Dr Peter A. Lio: “Explosion of New Treatments” for Atopic Dermatitis
Atopic dermatitis is a common disease that has seen an explosion of new treatments in the last decade, explained Peter A. Lio, MD, clinical assistant professor of pediatrics and dermatology, Northwestern Feinberg School of Medicine.
What We’re Reading: Abortion Rate Drops; Rebound of COVID-19 Symptoms; Marketplace Enrollment Opens
The legal abortion rate has fallen 6% since the overturning of Roe v Wade; 30% of patients with COVID-19 experienced a rebound in symptoms after 2 consecutive days without; open enrollment for Affordable Care Act marketplace insurance begins this week.
Combination of Tremelimumab and Durvalumab Approved by FDA for Unresectable Liver Cancer
A dual immunotherapy option of tremelimumab, sold as Imjudo, in combination with durvalumab, sold as Imfinzi, was approved by the FDA Monday for the treatment of adult patients with unresectable hepatocellular carcinoma, the most common type of liver cancer.
Endometriosis Has Quality-of-Life Impacts, Great Economic Burden, Dr Soyini Hawkins Says
Endometriosis can have a long timeline from onset of symptoms to diagnosis, and in later stages it can affect organs other than the uterus, explained Soyini Hawkins, MD, gynecologist at Fibroid and Pelvic Wellness Center of Georgia.